Aflac: Growing Cancer Cases Will Lead To Higher Revenues

mrsmuckers Overview Aflac (NYSE:AFL) remains a strong dividend growth company, despite the price underperforming the S&P 500 (SPY). I previously covered Aflac in December of 2023 and since then the total return has been a bit underwhelming at approximately 6%. This is in comparison to the S&P's total return of nearly 10%. However, if you zoom out to a larger three year time frame, AFL has severely outperformed in total return. The dividend growth remains strong due to the company's profitability metrics. Th ...